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Osteoporosis is a multi factorial disease with dimension of genetic and nutritional considerations. The aim of this study
was to present data from the association of plasma zinc, copper and toxic elements of lead and cadmium levels with
bone mineral density in Iranian women. 135 women gave their information and enrolled. Fasting plasma was used for
measurement of trace elements and heavy metals by Differential Pulse Anodic Stripping Voltammetry. Control group
(n = 51) were normal in both lumbar spine (L1-L4) and femoral neck density (T-score ≥ −1), but just femoral neck
T-score was considered as criterion in selection of patient group (n = 49, Tscore < −1). No differences were found
in the nutritional status, number of diseases, drugs and functional activities between these groups. Plasma Zn, Cu,
Pb, Cd levels were analyzed by, a method of voltammetry. Mean ± SD levels of copper and zinc was 1.168 ± 0.115,
1.097 ± 0.091 μg/ml in control group, 1.394 ± 0.133, 1.266 ± 0.11 μg/ml in total patient (TP) and 1.237 ± 0.182,
1.127 ± 0.176 μg/ml in Mild patients(−1 > T-score > −1.7), 1.463 ± 0.174, 1.327 ± 0.147 μg/ml in Severe patient
group (T-score < −1.7); respectively. Mean ± SD plasma level of lead and cadmium was 168.42 ± 9.61 ng/l,
2.91 ± 0.18 ng/ml in control group, 176.13 ± 8.64 ng/l, 2.97 ± 0.21 ng/ml in TP, 176.43 ± 13.2 ng/l, 2.99 ± 0.1 ng/ml in
mild patients, 221.44 ± 20 ng/l and 3.80 ± 0.70 ng/ml in severe patient group, respectively. In this study plasma
zinc, copper, lead & cadmium concentrations were higher in the patients than in the control, though differences
were not significant. However, differences were higher between the controls and patients with severe disease
(T-score < −1.7). In addition adjusted T-score of femur with age and BMI showed negative significant correlation
with plasma levels of zinc and lead in total participants (p < 0.05, r = −0.201, p = 0.044, r = −0.201). It seems that more
extensive study with larger ample size might supply definite results about this association for copper and cadmium.
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Osteoporosis is a skeletal disorder characterized by com-
promised bone strength predisposing to an increased
risk of fracture [1,2]. The introduction of bone density
measurement methods makes it possible to diagnose
osteoporosis before fractures occur. The World Health
Organization (WHO) has defined osteoporosis as a bone
mineral density (BMD) at the hip or spine that is ≤ −2.5
SDs (standard deviation) below the mean value for
young women, and osteopenia was defined as a BMD
that is between −1 and −2.5 SDs below this value [3].* Correspondence: janatbhr@sina.tums.ac.ir
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unless otherwise stated.Zinc is essential element for growth of human. Role of
zinc is demonstrated in the growth and mineralization
and preservation of bone tissue. Copper has an essential
role in the normal maturation of collagen, particularly in
the important steps to the formation of lysine- derived
cross-link [4,5]. Lead is a highly toxic metal that may
damage directly bone-forming cells (increasing chondro-
genesis, delaying cartilage mineralization) and alter the
hormonal regulation of Calcium and vitamin D3. Lead
has a negative effect on the processes regulating bone
turnover mechanisms and bone maturation or skeletal
growth. These changes may affect bone fragility and the
risk of fractures [6]. Lead will be retained in bone by
the replacement of calcium. Cadmium is a widespreadl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Comparison of age and BMI among control and
patient groups
Group Control Total patients
T-score > −1 T-score ≤ −1
(Mean ± SD)
n = 51 n = 49
Age (year) 48.17 ± 11.16 55.8 ± 12.38α
BMI (Kg/m2) 28.25 ± 50.02 25.8 ± 12.38α
αp <0.01.
Table 2 Femoral neck T-score and plasma concentrations
of Zn, Cu, Pb, Cd in smokers and non-smokers
Smokers Non-smokers
(Mean ± SD)
Participants (%) 12 88
Average T-score femur −1.49 ± 0.99 0.62 ± 1.3
Zinc (ng/ml) 1512 ± 258 1108 ± 59
Copper (ng/ml) 1572 ± 282 1290 ± 79
Lead (ng/l) 196.71 ± 20.93 169.47 ± 5.81
Cadmium (ng/ml) 2.98 ± 0.12 2.69 ± 0.42
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Cadmium may have both direct and indirect effects on
bone turnover [7,8]. Stripping voltammetry (SV) analysis
is powerful and simple tool to determination of trace el-
ements. In trace analysis of metal ions, Anodic stripping
voltammetry (ASV) is the most popular SV technique
[9]. The aim of this study is determination of plasma
levels of lead, cadmium, zinc and copper in osteoporotic
women comparison to control by voltammetric method
and how environmental toxins, lead and cadmium leads
to the pathogenesis of osteoporosis.
Methods
Apparatus
The polarograph set was Trace analyzer model 746 instru-
ments (Metrohm Ltd. Switzerland). Hanging Mercury
Drop Electrode (HMDE), Reference silver chloride elec-
trode (Ag/Agcl/kcl 3 M) and platinum (Pt) auxiliary elec-
trode were used.
Reagents
The chemical, CH3COONa.3H2O, Pb(NO3)2, Cd(NO3)2,
Cu(NO3)2, Zn(NO3)2 and HNO3 used in analytical grades
and were purchased from Merck Company Germany.
Stock solution (1 g/L) of 0.1 Molar nitric acid was pre-
pared. Hydrochloric acid (HCL) used to acidity the
plasma samples was Suprapur grade of Merck Company.
The stock solution (1 g/L) was prepared in 2.5 normal
HCL. The pH acetate buffer was adjusted between 4.6
and 4.8.
Sample preparation
In the present study, people were screened through a
total of approximately 1000 women that referred to bone
mineral densitometry division of Jami Clinic in Tehran,
Iran. 135 women gave their information and enrolled.
Participants were separated into three groups accord-
ing to T-score values suggested by WHO. The con-
trol group T-score is ≥ −1 and the total patients
(mild osteopenia + severe osteopenia + osteoporosis)
T-score < −1. The participants underwent a fasting blood
withdrawal in 10-ml heparinized tubes on the day of the
bone scan and then plasma was seprated. A number of
200 μL of plasma was added to 800 μL of 2.5 N hydro-
chloric acid to percipitate plasma proteins and centrifuged
for 15 min at 6000 rpm. Then the clear supernatant
passed from 0.2 micron filter before transferring to the po-
larographic cell. The complex composition of the plasma
may cause changes in the calibration slopes; that is why,
the zinc, copper, lead & cadmium concentrations were de-
termined using the standard addition technique with three
additions of standard stock solution. First 10 ml of 0.1 M
acetate buffer was used to set the blank polarogram. Next
500 μL of sample solution was added to polarographic celland the polarogram was plotted. After that 100 μL of the
standard stock solution was added to the cell for three
times and each time the polarogram was done. The cell
solution was deoxygenated by nitrogen for 300 seconds.
Determination was made on a Hanging mercury drop
electrode (HMDE). Determination of zinc and copper was
made after a collection period at a potential of −1200
and −500 mV respectively. Method was able to give esti-
mation of cadmium and lead simultaneously when a
sweep potential was applied between −800 and −100 mV.
The potential was swept, using a differential pulse anodic
stripping voltammetry (DPASV) [9,10]. Three determina-
tions were done for each sample, and the standard devia-
tions were calculated [10].
Ethical approval
The project was approved by Ethics Committee of Tehran
University of Medical Sciences (reference number of ap-
proval 89-01-33-10034).
Consent
We obtained in formed consent from all participants but
no patient was reported as a case.
Results and discussion
In the current study the level of zinc, copper, lead and
cadmium were determined in plasma of women with
osteoporosis. The total number of subjects was 135. The
T- score of both lumbar spine (L1-L4) and femoral neck
were measured in all participants. The control group
Table 3 Concentration of Zn, Cu, Pb, Cd in postmenopausal, Pre-menopausal, athlete and non-athlete participants
Athlete Non-athlete Pre-menopausal Post-menopausal
(Mean ± SD)
Zinc (μg /ml) 1.079 ± 0.138 1.171 ± 0.067 1.138 ± 0.080 1.163 ± 0.090
Copper (μg /ml) 1.107 ± 0.155 1.369 ± 0.088 1.233 ± 0.105 1.428 ± 0.110
Lead (ng/l) 166.63 ± 11.82 173.54 ± 6.51 174.66 ± 8.53 169.11 ± 6.91
Cadmium (ng/ml) 2.74 ± 0.16 3.09 ± 0.14 2.87 ± 0.16 3.05 ± 0.16
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including 51 women (37.8%). The total patient (mild
osteopenia + severe osteopenia + osteoporosis) had fem-
oral T-score < −1 including 49 women (36.3%) and
women with −1.7 ≤ T-score < −1 as mild osteopenia, pa-
tients with −2.5 < T-score < −1.7 as severe osteopenia
including 41 women (30.3%). The total number of sam-
ples from 35 (25.9%) were not including in the classifica-
tion of cases and controls; because of femoral T-score > −1
but lumbar T-score < −1, so they were analyzed in total
participants data. No difference in menopause, drugs, nu-
tritional habit, functional activities, stress and exposure
time in the sun was found between groups, but the differ-
ence was significant for smoking (P < 0.05), age and BMI
(P < 0.01) (Table 1). The concentrations of zinc, copper,
lead and cadmium in each patient division were com-
pared with control. The regression relationship be-
tween the amount of zinc, copper, lead and cadmium with
femoral T-score in control and patient groups were com-
pared. No significant relationship was detected between
age and BMI with the concentration of zinc, copper, lead
and cadmium. Zinc, copper, lead and cadmium levels are
higher in smokers than non-smokers, but the difference is
not significant (p = 0.266, p = 0.150, p = 0.146, p = 0.462
respectively). Results are shown in Table 2.
Also exercise and inactivity, menopause and pre-
menopausal status showed no significant effect on zinc,
copper, lead and cadmium levels. An inverse relationship
between age and femoral T-score is illustrated. Results are
shown in Table 3.
Morefurther, a direct and significant relationship be-
tween BMI and T-score of femur was detected. In this
study, plasma mean levels of zinc, copper, lead and cad-
mium were obtained for 135 samples. Results are shown
in Table 4.Table 4 Plasma Mean ± SD levels of Zn, Cu, Pb, Cd in differen
T-score > −1 T-score ≤ −1 −1.7 <
Zn (μg/ml) 1.1 ± 1.09 1.26 ± 0.11 1.13 ±
Cu (μg/ml) 1.17 ± 0.11 1.39 ± 0.13 1.24 ±
Pb (ng/l) 168.42 ± 0.01 176.13 ± 0.26 176.43
Cd (ng/ml) 2.91 ± 0.18 2.97 ± 0.21 2.99 ±The relationship between the concentrations of zinc,
copper, lead and cadmium were studied with the T-score
of femur Table 5.
For total participant’s of135 after matching with age
and BMI, plasma concentrations of Zn and Pb have a
statistically significant negative relationship with T-score
of femur. But the relationship between plasma concen-
trations of Cu and Cd with femoral T-score can be ob-
served probably after sample size increasing. The results
are shown in Table 6.
In this study, plasma zinc, copper, lead & cadmium
concentration among Iranian osteoporotic women showed
that: plasma zinc, copper, lead & cadmium concentra-
tion were higher in the patients than in the control,
though differences were not significant. However, differ-
ences were higher between the controls and patients
with severe disease (T-score < −1.7). In addition, T-score of
femur adjusted with interfere factors of age and BMI,
showed negative significant correlation with plasma levels
of Zn and Pb in the entire study population (p < 0.05,
r = −0.201, p = 0.044, r = −0.201 respectively). It seems
that more extensive study with larger ample size might
supply definite results about this reverse linear association
for copper and cadmium. Bone zinc content is decreased
by development of aging, bone loss, and post menopausal
conditions. The metal directly activates Aminoacyl-tRNA
synthetase in osteoblastic cells and it stimulates cellular
protein synthesis. Zinc may act on the process of bone-
resorbing factors induced protein kinase C activation,
which is involved in Ca+2 signaling in osteoclastic cells
[11]. Zinc is an essential trace element that is a cofactor of
more than 200 enzymes [12]. A decrease in the formation
of cross-linking amino acids is thought account in part for
the increased fragility of bone from copper-deficient [13].
Cadmium can interfere with vitamin D metabolism [7].t groups
T-score < −1 −2.5 < T-score < −1.7 T-score < −2.5
0.17 1.33 ± 0.15 1.27 ± 0.42
0.18 1.46 ± 0.17 1.71 ± 0.46
± 13.2 183.06 ± 10.91 221.4 ± 20
0.19 3.13 ± 0.29 3.80 ± 0.70
Table 5 Correlation between plasma concentrations of Zn, Cu, Pb, Cd and femoral T-score in different groups without
age and BMI matching
T-score < 2.5 T-score > −1 T-score ≤ −1 −1.7 < T-score < −1 −2.5 < T-score < −1.7 T-score < −2.5
Zn p: 0.041α 0.125 0.356 0.736 0.669 0.799
r: −0.181 −0.218 −0.135 −0.095 −0.076 −0.135
Cu p: 0.205 0.980 0.278 0.202 0.610 0.899
r: −0.113 −0.004 −0.188 −0.349 −0.091 −0.067
Pb p: 0.072 0.179 0.093 0.230 0.363 0.933
r: −0.160 −0.191 −0.243 −0.330 −0.161 −0.045
Cd p: 0.596 0.781 0.160 0.652 0.440 0.994
r: −0.047 −0.040 −0.204 −0.127 −0.137 −0.004
αp <0.05.
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only at high-level long-term exposure. Recent epidemio-
logical data indicate that Cd can damage the skeleton at
considerably lower exposure than previously anticipated;
however, the critical level of the exposure is still unknown.
Decreased bone density with increased risk of fractures
has been reported in conditions of low to moderate envir-
onmental exposure to Cd taking place in industrialized
countries. Until now, various mechanisms for the Cd-
induced bone damage involving both direct and indirect
action of this metal have been suggested, they might
explainthe indirect mechanism involves the Cd-induced
disorders in the metabolism of vitamin D and minerals
due to kidney and gastrointestinal tract damage [14].
In 2009 Smith et al. [15] reported that cadmium
causes apoptosis in human osteoblast-like Saos-2 cells.
They showed that cadmium exposure induces oxidative
stress which leads to decreased RUNX2 mRNA expres-
sion and increased apoptotic death, antioxidant NAC al-
leviates the damaging effects of cadmium. Furthermore
the osteoblast transcriptional factor RUNX2 is reported
to play a protective role against osteoporosis in post-
menopausal women. Cadmium can indirectly induce oxi-
dative stress through depletion of antioxidant molecules
or inhibition of antioxidant enzymes. Mounting world-
wide epidemiological research indicates that chronic, low
level exposure to lead and cadmium leads to increased risk
of bone fractures. The importance of the age factor in
bone density is obvious and known to increase the risk of
osteoporosis and bone density decreases [16]. The analysisTable 6 Correlation between concentrations of Zn, Cu, Pb
and Cd with femoral T-score in total population after age
and BMI matching
Zn Cu Pb Cd
Total participants p: 0.030α 0.063 0.044α 0.306
(T-score <2.5) r: −0.216 −0.186 −0.201 −0.103
αp <0.05.of the results of this study indicated that the plasma
concentrations of zinc, copper, lead and cadmium are
not affected by age. Plasma zinc and copper concentra-
tions were higher in those who did not exercise. Physical
activity has a negative association with plasma concentra-
tions of lead, though it is not significant. However, the
plasma concentration of cadmium was lower in athletes,
and this difference was significant (p < 0.01). In 2011
Margaret E. Sears [17] studied the amount of lead, cad-
mium, mercury and arsenic in sweat, so it was seen as
much more sweat as more excretion of these elements.
In other words more exercise means more perspiration
and excretion of these elements, so plasma levels of these
harmful elements reduce. Smoking is known as a cause
of bone mineral loss and may increase the risk of hip
fracture [18]. Polidori reports that α, γ tocopherol con-
centrations, α, β cryptoxanthin, retinol and ascorbate to
increases after 4 weeks smoking, significantly. In the
present study, we also observed an increase in plasma
antioxidant capacity in smokers, though is not significant
[19]. Kido et al. [20] study has shown an association be-
tween renal tubular dysfunction and decreased BMD in
examination of women environmentally exposed to cad-
mium. A study in 1988 by Wittmers et al. [21] was per-
formed for survey the effects of lead injection in bone
and skeletal tissue. It was seen that Lead makes some
spaces in bone. Lead cause snaping of Hydroxy apatit
crystals in calcification process. This toxic substance
remains in bone until remodeling. In a clinical study,
Saltman [22] has demonstrated the efficacy of Ca, Cu,
Mn and Zn supplementation in spinal bone mineral
density in postmenopausal women and the necessity of
trace elements for optimal bone matrix development and
bone density sustenance. Yamaguchi et al. [23] investi-
gated the effects of zinc on bone cells. Those cells that
were exposed to more zinc concentration, significantly
showed increased consumption of zinc, calcium, alkaline
phosphatase and ATPase activity, also collagen was in-
creased significantly. These findings suggest the direct
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stimulation of bone protein synthesis. Insufficient copper
intake in the diet can cause osteoporosis, bone calcium
and copper deficiency, bone abnormalities and curvature
of the spine. Suttle [24] showed that bone formation ac-
tivity is one of the first activities which are disrupted in
copper-deficient lambs. Our results showed more zinc
and copper levels in osteoporotic patients than controls,
although not significantly. Some studies indicated that
free radicals increase osteoporosis as well as the role of
antioxidants in their lack of support, so the disease can
progress. But it seems that the in oxidative stress disease,
antioxidants have always decreased, although this may still
be inadequate to meet the condition. Getting more antioxi-
dants can help prevent the progression of osteoporosis.
Conclusions
The comprehensive database shows that plasma levels of
zinc, copper, lead and cadmium in the osteoporotic women
is higher than control, though the differences were not sig-
nificant. It seems that more extensive study with larger size
might supply definite result about this association.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NS designed of the study, also coordinated research activities, and revised
the manuscript. MRO participated in data gathering. BJ carried out technical
analysis of data, participated in final revision of the manuscript. MB gathered
data and drafted the manuscript. MH and AB participated in the design of
the study. FS and SS participated in data analysis. All authors read and
approved the final manuscript.
Acknowledgements
Authors are grateful from the research deputy of Tehran University of Medical
Sciences for financial support in a project and thank the Pharmaceutical Sciences
Research Center for their help.
Author details
1Department of Drug and Food Control, School of Pharmacy, Tehran
university of Medical Sciences, Tehran, Iran. 2Halal research center, Ministry of
Health and Medical Education, Tehran, Iran. 3Department of Drug and Food
Control, Faculty of Pharmacy, Jondishapour Ahvaz University of Medical
Sciences, Ahvaz, Iran.
Received: 27 July 2013 Accepted: 14 October 2014
References
1. Handa R, Kalla AA, Maalouf GH: Osteoporosis in developing countries.
Best pract Res cl Rh 2008, 22(4):693–708.
2. Oveisi MR, Sadeghi N, Jannat B, Hajimahmoodi M, Hadjibabaie M, Behfar A:
Evaluation of antioxidants in bone mineral density of Iranian
osteoporotic women. IJBMS 2011, 14(2):158–166.
3. Jannat B, Oveisi MR, Sadeghi N, Hajimahmoodi M, Jamshidi AR, Izadi Dolagh G,
Behfar A, Gholami K, Behzad M: The erythrocyte catalase enzyme activity in
Iranian osteoporotic women. IJPS 2010, 6(1):19–24.
4. Hyun TH, Barrett-Connor E, Milne DB: Zinc intakes and plasma concentration
in men with osteoporosis : the rancho Bernardo study. Am J Clin Nutr 2004,
80:715–721.
5. Rucker R, Murray J: Cross-linking amino acids in collagen and elastin.
Am J Clin Nutr 1978, 31:1221–1236.6. Rodríguez-Estival J, Álvarez-Lloret P, Rodríguez-Navarro AB, Mateo R: Chronic
effects of lead (Pb) on bone properties in red deer and wild boar:
relationship with vitamins a and D3. Environ Pollut 2013, 174:142–149.
7. Wang H, Zhu G, Shi Y, Weng SH, Jin T, Kong Q, Nordberg G: Influence of
environmental cadmium exposure on forearm bone density. J Bone Miner
Res 2003, 18(3):553.
8. Akesson A, Bjellerup P, Lundh T, Lidfeldt J, Nerbrand C, Samsioe G, Skerfving S,
Vahter M: Cadmium-induced effects on bone in a population-based study of
women. Environ Health Perspect 2006, 114(6):830–834.
9. Chanlon S, Joly-Pottus L, Chatelut M, Vittori O, Cretier JL: Determination of
carmoisine, allura red ponceau 4R in sweets and soft drinks by differential
pulse polarography. J Food Comp Anal 2005, 18:503–515.
10. Thunus L, Lejeune R: Determination of Zn, Cu, Ni and Co by voltammetry
in plasma, without mineralisation. Anal Lett 1990, 23(5):901–921.
11. Yamaguchi M: Role of zinc in bone formation and bone resorption.
J Trace Elem Exp Med 1998, 11:119–135.
12. Otsuka M, Oshinbe A, Legeros RZ, Tokudome Y, Ito A, Otsuka K, Higuchi W:
Efficacy of the injectable calcium phosphate ceramics suspensions
containing magnesium, zinc and fluoride on the bone mineral
deficiency in ovariectomizad rats. J Pharm Sci 2008, 97:421–432.
13. Opsahl W, Zeronian H, Ellison M, Lewis D, Rucker RB, Riggins RS: Role of
copper in collagen cross-linking and its influence on selected mechanical
properties of chick bone and tendon. J Nutr 1982, 112:708–716.
14. Brzo’ska MM, Moniuszko-Jakoniuk J: Low-level lifetime exposure to cadmium
decreases skeletal mineralization and enhances bone loss in aged rats. Bone
2004, 35(5):1180–1191.
15. Smith SS, Rodriguez Reyes J, Arbon KS, Harvey WA, Hunt LM, Heggland SJ:
Cadmium-induced decrease in RUNX2 mRNA expression and recovery
by the antioxidant N-acetylcysteine (NAC) in the human osteoblast-like
cell line, saos-2. Toxicol in Vitro 2009, 23:60–66.
16. Gallagher JC, Riggs BL, Jerpbak CM, Arnaud CD: The effect of age on
serum immunoreactive parathyroid hormone in normal and
osteoporotic women. J Lab Clin Med 1980, 95(3):373–385.
17. Margaret ES, Kathleen JK, Riina IB: Arsenic, cadmium, lead, and mercury in
sweat. J Environ Public Health 2012, 2012:1–10.
18. Law MR, Hackshow AK: A meta-analysis of cigarette smoking, bone mineral
density and risk of hip fracture: recognition of a major effect. Brit Med J 1997,
315:841–860.
19. Polidori MC, Mecocci P, Stahl W, Sies H: Cigarette smoking cessation
increases plasma levels of several antioxidant micronutrients and
improves resistance towards oxidative challenge. Brit J Nut 2000,
90:147–150.
20. Kido T, Nogawa K, Honda R, Tsuritani I, Ishizaki M, Yamada Y, Nakagawa H:
The association between renal dysfunction and osteopenia in environmental
cadmium-exposed subjects. Environ Res 1990, 51:71–82.
21. Wittmers LE, Aufderheide AC, Wallgren J, Rapp G, Alich A: Lead in bone. IV.
Distribution of lead in the human skeleton. Arch Environ Health 1988,
43(6):381–391.
22. Saltman PD, Strause LG: The role of trace minerals in osteoporosis. J Am
Coll Nutr 1993, 12(4):384–389.
23. Yamaguchi M, Oishi H, Suketa Y: Stimulatory effect of zinc on bone
formation in tissue culture. Biochem Pharm 1987, 36(22):4007–4012.
24. Suttle NF: Osteoporosis in copper-depleted lambs. J Comp Pathol
1972, 82(1):93–96.
doi:10.1186/s40201-014-0125-3
Cite this article as: Sadeghi et al.: The relationship between bone health
and plasma zinc, copper lead and cadmium concentration in
osteoporotic women. Journal of Environmental Health Science & Engineering
2014 12:125.
